Genome Editing Market

Genome Editing/Genome Engineering Market worth $6.3 billion by 2022

The increasing government funding and growth in the number of Genome Editing/Genome Engineering Market, increasing the production of genetically modified crops, and the growing application areas of genomics are the key factors driving the growth of the genome editing market. The growth of this market is supported further by the technological advancements in genome editing/genome engineering and the rising prevalence of infectious diseases and cancer.

Browse 96 market data Tables and 42 Figures spread through 164 Pages and in-depth TOC on "Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs) - Global Forecast 2022"

View detailed Table of Content here -

CRISPR is the largest technology segment in the genome editing/genome engineering market

Based on technology, the market is categorized into CRISPR, ZFN, antisense, TALEN, and other technologies. In 2017, the CRISPR segment held the largest share of this market and was also estimated to witness the highest growth rate during the forecast period. The ability of CRISPR to use multiple guide RNAs in parallel to target multiple sites simultaneously, in the same cell, makes it easier to mutate multiple genes at once or engineer precise deletions in a genomic region. This key advantage is driving the adoption of CRISPR in the market.

The cell line engineering segment is estimated to grow at the highest rate from 2017 to 2022

The applications of genome editing have been classified into genetic engineering, cell line engineering, and other applications (diagnostics and therapeutics). The cell line engineering segment is estimated to grow at the highest CAGR during the forecast period. This segment also held the majority share of the market in 2017. Factors such as the increasing industry focus on stem cell research, growing funding from governments & private organizations, and rising awareness about stem cell therapies are driving the growth of this segment.

North America is the largest regional market for genome editing/genome engineering

North America dominated the genome editing/genome engineering market in 2017. This regional market is also estimated to grow at the highest rate from 2017 to 2022. The growing use of genetically modified crops and the increasing focus on the development of gene therapies in the US are the primary drivers for market growth in this region. Other factors such as the increasing prevalence of infectious diseases and cancer and the growing availability of research grants and funding are also supporting the growth of this market.

Thermo Fisher Scientific (US), Horizon Discovery Group (UK), Merck (Germany), GenScript (US), Sangamo BioSciences (US), Lonza Group (Switzerland), Integrated DNA Technologies (US), New England Biolabs (US), OriGene Technologies (US),Editas Medicine (US), Transposagen Biopharmaceuticals (US), and CRISPR Therapeutics (Switzerland) are some of the key players operating in the genome editing/genome engineering market.

Don’t miss out on business opportunities in Genome Editing/Genome Engineering Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441

Report Code
BT 3380
PR Published ON
Choose License Type
Request Customization
Speak to Analyst
Speak to Analyst
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
  • What are the Known and Unknown Adjacencies Impacting the Genome Editing/Genome Engineering Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
© MarketsandMarkets Research Private Ltd. All rights reserved

Digital Virtual Assistant - MarketsandMarkets